Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate Cancer

Clin Oncol (R Coll Radiol). 2017 Oct;29(10):e174-e175. doi: 10.1016/j.clon.2017.06.006. Epub 2017 Jun 23.

Authors

A Patrikidou¹, M Uccello², A Tree¹, C Parker², G Attard¹, R Eeles³, V Khoo³, N van As⁴, R Huddart¹, D Dearnaley¹, A Reid²

Affiliations

¹ Academic Uro-Oncology Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK; The Institute of Cancer Research, London, UK.
² Academic Uro-Oncology Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK.
³ The Institute of Cancer Research, London, UK; Urology Oncology Unit, The Royal Marsden NHS Foundation Trust, London, UK.
⁴ Urology Oncology Unit, The Royal Marsden NHS Foundation Trust, London, UK.

PMID: 28652092
DOI: 10.1016/j.clon.2017.06.006

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

Grants and funding